Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

TNNI3K

TNNI3 interacting kinase

translation score 0.48, read 2026-10-24; 2 sealed predictions, 0 held; 3 receipts.

Six readers

readerfoundscore
genetics
Open Targets
no genetic evidence; overall 0.01 from other evidence0.00
cell type
Human Protein Atlas
cell type enhanced, including oligodendrocytes; strongest in ependymal cells0.75
chemistry
Open Targets
a small-molecule pocket0.60
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
no papers tie it to Parkinson's yet1.00
pathways
Reactome
in no curated pathway0.00

No case: the score is under the bar. Receipt 8661

Sealed predictions

  1. TNNI3K in dopamine neurons, braak+0.64 (p 0.063) → +0.53 (p 0.143)receipt 8669
  2. TNNI3K in oligodendrocytes, braak-0.35 (p 0.360) → -0.32 (p 0.400)receipt 8668

Swarm cases

receipt 8669: TNNI3K in dopamine neurons, braak

power
full sample +0.46 (p 0.054, n 18), 95% CI -0.01 to +0.76. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.40 (p 0.101, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.39 (p 0.111, n 18). could be the mix.
skeptic
leave-one-out range +0.39 to +0.60, sign flips 0; without severely affected donors +0.46 (p 0.054, n 18). robust.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for TNNI3K in dopamine neurons.

case closed: nothing better to follow up.

receipt 8668: TNNI3K in oligodendrocytes, braak

power
full sample -0.27 (p 0.281, n 18), 95% CI -0.65 to +0.23. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.31 (p 0.211, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.28 (p 0.265, n 18). could be the mix.
skeptic
leave-one-out range -0.41 to -0.16, sign flips 0; without severely affected donors -0.27 (p 0.281, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for TNNI3K in oligodendrocytes.

case closed: nothing better to follow up.

Receipts

loading the receipts